$58.22
0.07% today
Nasdaq, Apr 01, 06:51 pm CET
ISIN
US74276L1052
Symbol
PRCT
Sector

PROCEPT BioRobotics Stock price

$58.26
-6.08 9.45% 1M
-21.86 27.28% 6M
-22.26 27.65% YTD
+11.26 23.96% 1Y
+23.27 66.50% 3Y
+16.32 38.91% 5Y
+16.32 38.91% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
-1.79 2.98%
ISIN
US74276L1052
Symbol
PRCT
Sector

Key metrics

Market capitalization $3.19b
Enterprise Value $2.94b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 13.10
P/S ratio (TTM) P/S ratio 14.23
P/B ratio (TTM) P/B ratio 7.93
Revenue growth (TTM) Revenue growth 64.84%
Revenue (TTM) Revenue $224.50m
EBIT (operating result TTM) EBIT $-96.61m
Free Cash Flow (TTM) Free Cash Flow $-103.62m
Cash position $333.73m
EPS (TTM) EPS $-1.76
P/E forward negative
P/S forward 9.92
EV/Sales forward 9.13
Short interest 14.32%
Show more

Is PROCEPT BioRobotics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

PROCEPT BioRobotics Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a PROCEPT BioRobotics forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a PROCEPT BioRobotics forecast:

Buy
82%
Hold
18%

Financial data from PROCEPT BioRobotics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
225 225
65% 65%
100%
- Direct Costs 91 91
32% 32%
41%
133 133
99% 99%
59%
- Selling and Administrative Expenses 166 166
30% 30%
74%
- Research and Development Expense 59 59
32% 32%
26%
-91 -91
13% 13%
-41%
- Depreciation and Amortization 5.23 5.23
27% 27%
2%
EBIT (Operating Income) EBIT -97 -97
11% 11%
-43%
Net Profit -91 -91
14% 14%
-41%

In millions USD.

Don't miss a Thing! We will send you all news about PROCEPT BioRobotics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PROCEPT BioRobotics Stock News

Neutral
GlobeNewsWire
8 days ago
Aquablation therapy delivers similar symptom score reduction, superior ejaculatory function preservation, and superior continence preservation to laser enucleation in 80–180 mL prostates in a randomized, multicenter trial Aquablation therapy delivers similar symptom score reduction, superior ejaculatory function preservation, and superior continence preservation to laser enucleation in 80–180 m...
Neutral
GlobeNewsWire
18 days ago
SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today it will host an in-person investor event on Friday, April 25, 2025, at the Venetian Hotel in Las Vegas at the American Urological Association Annual Me...
Positive
Seeking Alpha
21 days ago
PROCEPT BioRobotics shows strong revenue growth and expanding market presence but struggles with profitability and rising operational costs. The company's HYDROS robotic system and consumables business are driving revenue, with significant expansion in the U.S. and promising international growth. The FDA's clearance for Aquablation therapy in prostate cancer patients presents a long-term opport...
More PROCEPT BioRobotics News

Company Profile

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.

Head office United States
CEO Reza Zadno
Employees 756
Founded 2007
Website www.procept-biorobotics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today